Charles Schwab
STIM icon

Charles Schwab’s Neuronetics STIM Stock Holding History

Charles Schwab’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-82,123
Closed -$119K – 3549
2026
Q1 		$119K Sell
82,123
-9,006
-10% -$14.3K ﹤0.01% 3363
2025
Q4 		$126K Sell
91,129
-15,000
-14% -$31.4K ﹤0.01% 3384
2025
Q3 		$290K Hold
106,129
– – ﹤0.01% 3302
2025
Q2 		$370K Buy
106,129
+91,129
+608% +$360K ﹤0.01% 3249
2025
Q1 		$55.2K Buy
+15,000
New +$54.8K ﹤0.01% 3394
2023
Q3 		– Sell
-13,837
Closed -$29.8K – 3621
2023
Q2 		$29.8K Hold
13,837
– – ﹤0.01% 3510
2023
Q1 		$40.3K Hold
13,837
– – ﹤0.01% 3384
2022
Q4 		$95.1K Hold
13,837
– – ﹤0.01% 3266
2022
Q3 		$45K Hold
13,837
– – ﹤0.01% 3357
2022
Q2 		$45K Sell
13,837
-54,771
-80% -$159K ﹤0.01% 3406
2022
Q1 		$208K Buy
68,608
+1,812
+3% +$6.13K ﹤0.01% 3299
2021
Q4 		$298K Hold
66,796
– – ﹤0.01% 3288
2021
Q3 		$439K Buy
66,796
+4,965
+8% +$47.6K ﹤0.01% 3183
2021
Q2 		$991K Buy
+61,831
New +$854K ﹤0.01% 2936
2020
Q2 		– Sell
-36,954
Closed -$70K – 3352
2020
Q1 		$70K Hold
36,954
– – ﹤0.01% 3133
2019
Q4 		$166K Hold
36,954
– – ﹤0.01% 3059
2019
Q3 		$308K Buy
36,954
+8,872
+32% +$96.9K ﹤0.01% 2964
2019
Q2 		$352K Buy
28,082
+443
+2% +$6.26K ﹤0.01% 2966
2019
Q1 		$422K Buy
27,639
+13,749
+99% +$227K ﹤0.01% 2824
2018
Q4 		$269K Hold
13,890
– – ﹤0.01% 2966
2018
Q3 		$446K Buy
+13,890
New +$422K ﹤0.01% 2882

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Charles Schwab's STIM Position: Q2 2026 in Review

Charles Schwab sold out of Neuronetics (STIM) in Q2 2026, closing a stake of 82,123 shares — an estimated $119K sold.

Charles Schwab first reported a position in STIM in Q3 2018 and held it in 21 quarters. The position peaked at $991K in Q2 2021. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Charles Schwab reported no remaining Neuronetics position as of Q2 2026 after selling out during the quarter.
  • Charles Schwab sold 82,123 Neuronetics shares in Q2 2026, an estimated $119K.
  • Charles Schwab first reported a position in Neuronetics in Q3 2018 and held it in 21 quarters.
  • Charles Schwab's Neuronetics position peaked at $991K in Q2 2021.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.